News from pharmaventures A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

08 Jan, 2020, 09:00 GMT PharmaVentures Strengthens its M&A and Fundraising Capabilities with the Appointment of a New Managing Director, Robert Gebhardt

PharmaVentures is pleased to announce the appointment of Robert Gebhardt as a Managing Director. Robert is an experienced investment banking...


30 Sep, 2019, 09:00 BST PharmaVentures Strengthens Its Global Reach with the Establishment of an International Advisory Board

PharmaVentures is pleased to announce the establishment of a new International Advisory Board, comprised of pharmaceutical, medical, transactional...


06 Sep, 2018, 11:45 BST PharmaVentures Advises Vital Foods on the Sale of its Zyactinase-based Digestive Health Product Asset Portfolio to Mundipharma

PharmaVentures Ltd. ("PharmaVentures") is pleased to announce that it acted as exclusive adviser to Vital Food Processors Ltd ("Vital Foods"), an...


28 Oct, 2016, 12:00 BST PharmaVentures Advises IDT Australia on the Divestment of CMAX Clinical Trial Business to the Japanese Company I'rom Group Co. Ltd.

PharmaVentures is pleased to announce that it acted as adviser to IDT Australia Limited for the successful divestment of CMAX, a dedicated clinical...


28 Jul, 2016, 10:00 BST PharmaVentures Advises the Baylor Scott & White Research Institute on Collaboration With Abzena plc and Creation of Denceptor Therapeutics

PharmaVentures is pleased to announce that it acted as an adviser to the Baylor Scott & White Research Institute in connection with the creation of...


22 Mar, 2016, 10:28 GMT PharmaVentures Advises 3Legs Resources on its Acquisition of the Immuno-Oncology Company SalvaRx Who Announced its Admission for Trading on AIM Today

PharmaVentures is pleased to announce that it acted as an independent technical and commercial expert adviser to 3Legs on its Reverse Takeover of...


04 Feb, 2016, 10:00 GMT PharmaVentures Advises Transgene on the Sale of Their Biopharmaceutical Manufacturing Plant

PharmaVentures is pleased to announce that it acted as an advisor to Transgene on the sale of its biopharmaceutical manufacturing unit in Strasbourg, ...


17 Dec, 2015, 09:00 GMT PharmaVentures Advises Stericool on Sale to Sweden's Getinge Group

PharmaVentures is pleased to announce that it acted as advisor to Stericool on its sale to Sweden's Getinge Group, a global leader in infection...


11 Apr, 2014, 14:52 BST Novartis Appoints PharmaVentures as Advisors on the Future of its UK Horsham Site

PharmaVentures is pleased to announce that it has been appointed by Novartis as advisors on the future options for its UK Horsham site. These options ...


30 Sep, 2013, 11:37 BST PharmaVentures Acts as Exclusive Advisor to NanoSight in its Successful Sale to Malvern Instruments

PharmaVentures is pleased to announce that it has acted as exclusive M&A advisor to NanoSight in the successful sale of the company to Malvern...


11 Apr, 2013, 17:14 BST PharmaVentures acts as Exclusive Advisor on the Sale of a Majority Stake in Doğu Tip, a Turkish Diagnostic Imaging Services Company,to Techno Group Investment Holdings, a Gulf Capital Portfolio Company

PharmaVentures is pleased to announce that Techno Group Investment Holdings, a portfolio company of Gulf Capital, has acquired 100% of Doğu Tip, a...


19 Dec, 2012, 12:13 GMT PharmaVentures Acts as Exclusive Advisor to Sanofi in the Divestment of Zentiva's Hlovovec Production Facility to Wood Pharma Holding

PharmaVentures is pleased to announce that it has acted as transaction advisors and sale process executioners for Sanofi. The current deal covers...


18 Oct, 2012, 11:41 BST Stephen Waterman Joins PharmaVentures

PharmaVentures today announced the appointment of Stephen Waterman as Vice President in its Corporate Advisory business, significantly enhancing...


21 Mar, 2012, 13:48 GMT PTV Interview Exclusive: Revolutionary GSK and J&J Participation in New Index Ventures Fund

Fintan Walton talks exclusively to Johnson & Johnson (J&J) and GlaxoSmithKline (GSK) about their participation in Index Ventures' latest fund...


25 Jan, 2012, 17:25 GMT Deal-making Declines by 18% in a Year as Pharmaceutical Companies Tighten Their Belt

Overall pharmaceutical deal-making activity fell by 18% in 2011 as pharmaceutical companies cut R&D expenditure and streamlined their research and...


19 Jan, 2012, 12:49 GMT PharmaVentures Helps Secure Investor for Former MSD Research Site

PharmaVentures announced today that it was delighted to act as transaction advisor to MSD (operating in the US and Canada as Merck & Co) to secure...


20 Oct, 2011, 10:27 BST Pfizer, Sanofi and Genentech Feature Prominently in the Oncology Edition of PharmaDeals' New Publication Series; Essential Deal Trends

PharmaVentures today announced the launch of PharmaDeals®Essential Deal Trends: Oncology 2011. This new series of reports is essential reading for...


04 Oct, 2011, 08:00 BST PharmaVentures Appoints Andy Smith as Head of Corporate Finance

PharmaVentures today announced the appointment of Andy Smith as Head of Corporate Finance to significantly enhance Pharmaventures' advisory...


12 Jul, 2011, 08:00 BST PharmaVentures Engaged by Avexa to Assist in the Out-licensing of Apricitabine

PharmaVentures Limited, experts in deals and alliances, are pleased to announce that they have been engaged by Avexa Limited to seek an out-licensing ...


07 Jun, 2011, 07:30 BST PharmaVentures Corporate Advisory Appoints Ping Shek as Senior Director in Transactions

PharmaVentures today announced the appointment of Ping Shek as Senior Director in the Transactions division of Corporate Advisory working on a number ...


22 Feb, 2011, 07:30 GMT PharmaDeals Research Reveals Early Signs of Recovery in Pharma Industry Deal Making

PharmaDeals(R) research has revealed that the early stages of recovery are now evident within pharmaceutical deal-making activity. The overall number ...